Newsroom

NEW ORLEANS--(BUSINESS WIRE)--Posterpresentatie van Diabetology Limited (Jersey) (https://diabetology.co.uk/ada-poster) 1724-P tijdens de ADA 86e Scientific Session, New Orleans, rapporteert de eerste menselijke gegevens van Oraglutide™ — klein pilletje in de darm vrijkomende orale semaglutide, samengesteld aan de hand van de eigen Axcess™-afgiftetechnologie. BELANGRIJKSTE HOOGTPUNTEN 6-daagse glucosecontrole: één enkele orale dosis van 4 mg Oraglutide™ produceerde een aanhoudende glucoseverlag...

NEW ORLEANS--(BUSINESS WIRE)--La presentazione poster di Diabetology Limited (Jersey) (https://diabetology.co.uk/ada-poster) 1724-P alla 86a Sessione scientifica dell'ADA, a New Orleans, ha illustrato i primi dati umani su Oraglutide™, una piccola capsula di semaglutide orale rilasciata a livello intestinale, formulata utilizzando la tecnologia di rilascio proprietaria Axcess™. PUNTI SALIENTI Controllo del glucosio in 6 giorni: un'unica dose orale da 4 mg di Oraglutide™ ha prodotto una riduzion...

NOVA ORLEANS--(BUSINESS WIRE)--Diabetology Limited (Jersey) (https://diabetology.co.uk/ada-poster) 1724-P na 86ª Sessão Científica da ADA, em Nova Orleans, relatando os primeiros dados em humanos do Oraglutide™ — semaglutida oral de liberação intestinal em pequenas cápsulas, formulada com a tecnologia proprietária de administração Axcess™. PRINCIPAIS DESTAQUES Controle glicêmico por 6 dias: Uma única dose oral de 4 mg de Oraglutide™ produziu uma queda sustentada na glicose. Medindo 14% no 6º di...

PHILADELPHIA--(BUSINESS WIRE)--WhiteHawk Income Corporation (“WhiteHawk Minerals” or the “Company”) today announced the pricing of the upsized initial public offering of 7,700,000 shares of its Class A common stock at a price to the public of $26.00 per share. The 7,700,000 share offering represents a 775,000 share upsize to the originally proposed 6,925,000 share offering. The Company has granted the underwriters a 30-day option to purchase up to an additional 1,155,000 shares of its Class A c...

NUEVA ORLEANS--(BUSINESS WIRE)--Presentación de Diabetology Limited (Jersey) de póster 1724-P (https://diabetology.co.uk/ada-poster) en la 86.ª Sesión Científica de la American Diabetes Association (ADA), celebrada en Nueva Orleans, con los primeros datos en humanos de Oraglutide™, una semaglutida oral de liberación intestinal en cápsulas pequeñas, formulada con la tecnología de administración patentada Axcess™. ASPECTOS DESTACADOS Control de glucosa durante 6 días: una dosis oral única de 4 mg...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against GeneDx Holdings Corp. (NasdaqGS: WGS) (“GeneDx” or the “Company”), if they purchased or otherwise acquired the Company’s shares between April 16, 2025 and May 4, 2026, inclusive (the “Clas...

OSAKA, Giappone--(BUSINESS WIRE)--Capcom Co., Ltd. (TOKYO:9697) oggi ha annunciato che il lancio di Resident Evil Veronica, l'ultimo titolo nella serie Resident Evil, è previsto per il 2027. La saga Resident Evil comprende giochi di sopravvivenza in contesti di orrore, nei quali i giocatori si servono di una varietà di armi e altri oggetti per sopravvivere in situazioni terrificanti. Grazie a una base di appassionati giocatori a livello globale, le vendite complessive dei giochi fin dal primo t...

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Verra Mobility Corporation (“Verra Mobility” or the “Company”) (NASDAQ:VRRM) securities during the period of February 24, 2026 through May 26, 2026, inclusive (“the Class Period”).If you suffered a loss on your Verra Mobility investments, you have until August 4, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff ap...

SYDNEY--(BUSINESS WIRE)--Grafana Labs, the company behind the open observability cloud, today announced that PointsBet, one of Australia’s fastest-growing digital wagering operators, has selected Grafana Cloud as its unified observability platform. PointsBet is using Grafana Cloud to consolidate telemetry across its proprietary betting platform, accelerate incident resolution with AI-powered insights, and give engineering teams the visibility they need to own and operate their services with con...

NEW ORLEANS--(BUSINESS WIRE)--Posterpräsentation von Diabetology Limited (Jersey) (https://diabetology.co.uk/ada-poster) 1724-P im Rahmen der 86. ADA-Wissenschaftstagung in New Orleans, in der erste Daten aus Humanstudien zu Oraglutide™ vorgestellt wurden — einem in kleinen Kapseln verabreichten, im Darm freigesetzten oralen Semaglutid, das unter Verwendung der firmeneigenen Axcess™-Verabreichungstechnologie entwickelt wurde. DIE WICHTIGSTEN HIGHLIGHTS 6-Tage-Glukosekontrolle: Eine einmalige or...